A Study Exploring the Safety, Tolerability and Efficacy of a 4 Week Course of INCB018424 in Subjects With Active Rheumatoid Arthritis

• Status: Completed
• Trial end date: 2008-09-01

Summary

The purpose of this study is to understand the safety and tolerability of INCB018424 in patients with rheumatoid arthritis

• Phase: Phase 2

Details

• Lead Sponsor: Incyte Corporation